Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences.

Alexander T CohenJanvi SahAmol D DhamaneDionne M HinesTheodore LeeLisa RosenblattBirol EmirAllison KeshishianHuseyin YuceXuemei Luo

Published in: Advances in therapy (2023)

Patients with prescription fills for apixaban had lower risk of recurrent VTE, MB, and CRNM bleeding compared with warfarin patients. Treatment effects of apixaban vs warfarin were generally consistent across subgroups of patients at increased risk of bleeding/recurrences.

Keyphrases

venous thromboembolism
atrial fibrillation
direct oral anticoagulants
oral anticoagulants
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis